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The endosomal sorting complexes required for
transport (ESCRTs) constitute hetero-oligomeric
machines that mediate topologically similar mem-
brane-sculpting processes, including cytokinesis,
retroviral egress, and multivesicular body (MVB)
biogenesis. Although ESCRT-III drives membrane
remodeling that creates MVBs, its structure and the
mechanism of vesicle formation are unclear. Using
electron microscopy, we visualize an ESCRT-II:
ESCRT-III supercomplex and propose how it medi-
ates vesicle formation. We define conformational
changes that activate ESCRT-III subunit Snf7 and
show that it assembles into spiraling9 nmprotofila-
ments on lipid monolayers. A high-content flow cy-
tometry assay further demonstrates that mutations
halting ESCRT-III assembly block ESCRT function.
Strikingly, the addition of Vps24 and Vps2 transforms
flat Snf7 spirals into membrane-sculpting helices.
Finally, we show that ESCRT-II and ESCRT-III coas-
semble into 65 nm diameter rings indicative of
a cargo-sequestering supercomplex. We propose
that ESCRT-III has distinct architectural stages that
aremodulated by ESCRT-II to mediate cargo capture
and vesicle formation by ordered assembly.INTRODUCTION
The endosomal sorting complexes required for transport
(ESCRTs) constitute the sorting machinery that delivers ubiquiti-
nated transmembrane cargoes from the endosomal surface into
its interior and ultimately into the vacuole lumen (lysosome in
mammals). To ensure vacuole delivery, cell-surface cargoes
are ubiquitinated, endocytosed, and trafficked to endosomes.
There, the ESCRT machinery recognizes their ubiquitin moiety
and mediates their deubiquitination before packaging them
into intralumenal vesicles (ILVs) that bud into the interior of late356 Cell 151, 356–371, October 12, 2012 ª2012 Elsevier Inc.endosomes, creating multivesicular bodies (MVBs). MVB bio-
genesis is achieved by the coordinated action of five distinct
ESCRT complexes (ESCRTs-0, -I, -II, -III, and the Vps4-Vta1
complex) (Babst, 2011; Henne et al., 2011). The failure of
ESCRTs to properly sort cargoes is associated with numerous
pathologies, including cancer and various neurodegenerative
diseases (Saksena and Emr, 2009). Furthermore, many viruses,
including HIV-1, rely on ESCRT machinery to exit infected cells,
highlighting the central role of the ESCRT pathway in the study of
human disease.
The ESCRT pathway executes MVB biogenesis through an
exquisite division of labor. ESCRTs-0, -I, and -II are soluble
hetero-oligomers that are recruited to cargo-laden endosomes
by binding both the compartment-specific lipid phosphatidylino-
sitol-3-phosphate (PtdIns(3)P) and ubiquitin-modified cargo.
In addition, the ESCRT-II complex also initiates the assembly
of ESCRT-III. This hetero-oligomeric complex is composed of
four core subunits (Vps20, Snf7/Vps32, Vps24, and Vps2;
CHMPs in mammals) and has recently been highlighted as the
minimal machinery necessary to form ILVs in vitro (Hanson
et al., 2008; Saksena et al., 2009; Wollert and Hurley, 2010).
Previous studies indicate that ESCRT-III does not assemble
into a stable complex. Rather, its subunits cycle between an
inactive monomeric state in the cytoplasm and an assembled
polymer at endosomes (Babst et al., 2002). ESCRT-III assembly
is thus both temporally ordered and transient. ESCRT-II engages
Vps20 and triggers Snf7 homo-oligomerization. Snf7 then
recruits Vps24 and Vps2, which contain high-affinity microtu-
bule-interacting and trafficking (MIT)-interacting motifs (MIMs)
necessary to recruit the ATPases associated with diverse
activities (AAA) ATPase Vps4 to immediately disassemble the
complex (Saksena et al., 2009; Teis et al., 2008).
Intralumenal vesicle formation is directly coupled to the
ordered assembly of ESCRT-III. This is a biologically unique
form of vesicle budding that is topologically inverted from ‘‘clas-
sical’’ vesicle formation (e.g., clathrin and coat protein complex
[COP] coated) (Doherty and McMahon, 2009). As such, the
mechanism for ILV formation is unclear. Furthermore, themolec-
ular architecture that ESCRT-III adopts to drive ILV formation
remains a key question in the field. Previous studies indicate
that ESCRT-III assembly is initiated by conformational changes
in each of its subunits that promote their association with each
other and the endosome. These conformational changes involve
the disruption of intramolecular interactions between the basic N
terminus with the acidic C-terminal region (Shim et al., 2007;
Zamborlini et al., 2006). In agreement with this, recent X-ray
crystal structures show that soluble ESCRT-III subunits exist in
‘‘closed’’ conformations with numerous intramolecular interac-
tions between the highly structured N-terminal ‘‘core domain’’
and the more flexible C terminus (Bajorek et al., 2009; Muzio1
et al., 2006) (Figure 1A). Subunit truncations, which remove these
autoinhibitory C-terminal regions, result in subunit autoactivation
and the spontaneous assembly of ESCRT-III polymers in vivo
and in vitro (Hanson et al., 2008; Lata et al., 2008). However,
past studies display one or more limitations: (1) they rely on the
extensive manipulation of ESCRT-III subunits, often deleting up
to 48% of subunits to drive polymer assembly; (2) polymers
are very heterogeneous and form linear protofilaments, rings,
domes, cylinders, and sheet-like lattices, making their physio-
logical relevance unclear; (3) they are not comprehensive and
focus on only one or a few ESCRT subunits; or (4) microscopic
visualization of ESCRT-III on lipidmembranes is generally limited
to the resolution of light microscopy.
Here, we elucidate the molecular architecture of the ESCRT-III
complexes that assemble on lipid monolayers. Furthermore,
by reconstituting and visualizing distinct subreactions of
ESCRT-III assembly, we present a comprehensive structural
explanation elucidating how transmembrane cargoes are first
sequestered and ultimately sorted into ILVs.
RESULTS
Experimental Rationale
To investigate the molecular mechanism governing ESCRT-III
assembly, we designed a three-stage research strategy. In the
first stage, we investigated the conformational changes that
convert ESCRT-III subunits from inactive monomers into an
assembled complex. We began by mapping regions shared by
all four ESCRT-III core subunits, which are necessary for
assembly into a complex, and then focusing on Snf7, the most
abundant subunit within ESCRT-III, as a model to indentify
conformational changes that promote its activation. In the
second stage, we reconstituted Snf7 assembly on lipid mono-
layers and addressed the molecular mechanism governing
Snf7 homo-oligomerization. In our final stage, we visualized the
coassembly of ESCRTs-II and -III and proposed a model
describing how ESCRT-III is transformed from a cargo-capturing
ring into a membrane-sculpting helix to achieve cargo sorting
into MVBs.
ESCRT-III ‘‘Core’’ Domains Mediate ESCRT-III Assembly
Previous studies demonstrate that ESCRT-III subunits are
sequentially recruited by ESCRT-II to the surface of endosomes
(Teis et al., 2008). ESCRT-II directly binds Vps20, which
promotes the sequential recruitment of Snf7, Vps24, and Vps2
to form the heterotetrameric ESCRT-III complex (Figure 1A)
(Teis et al., 2008). All four of these ESCRT-III subunits are pre-
dicted to share a common domain architecture of four a helices
bundled into an N-terminal core domain, followed by an unstruc-tured C-terminal region (Figure 1A). To better understand the
molecular architecture of the ESCRT-III complex, we first wanted
to define architectural regions shared by its subunits that govern
protein-protein and protein-endosome interactions.
To do this, we generated subunit truncations for each
ESCRT-III subunit and asked whether they retained endosomal
localization and could interact with other ESCRT subunits. The
N-terminal core domains (which lack their C-terminal regions
and contain only a helices 1–4) of Vps20, Snf7, Vps24, and
Vps2 were fused to green fluorescent protein (GFP) and ectopi-
cally expressed in yeast lacking an endogenous copy of each
subunit. Like their full-length counterparts, the core domains of
all four ESCRT-III subunits localize to distinct intracellular punc-
tae (Figures 1B–1D and Figure S1A available online).
We hypothesized that these punctae were class E compart-
ments, aberrant endosome-derived structures generated when-
ever the ESCRT pathway is blocked (Raymond et al., 1992). To
confirm this, yeast were colabeled with the fluorescent
membrane dye FM4-64, which accumulates in class E compart-
ments. Vps20core, Snf7core, Vps24core, and Vps2core-GFP all co-
localize with FM4-64, confirming their endosomal localization.
We next asked whether each ESCRT-III core domain was
sufficient to recruit a downstream ESCRT-III subunit to endoso-
mal membranes. To test this, we took advantage of the
observation that Snf7-GFP normally localizes to the class E
compartment but is redistributed into the cytoplasm in vps20D
cells (Figure 1E). Ectopic expression of Vps20core rescues
Snf7-GFP endosomal localization, confirming that Vps20core is
sufficient to recruit Snf7 (Figure 1E). Similar experiments in
snf7D and vps24D yeast confirm that both Snf7core and
Vps24core are sufficient to recruit their respective downstream
subunits (Vps24 and Vps2, respectively) to endosomal
membranes (Figures 1F and 1G). Further truncation of Snf7 to
helices1–3 proved insufficient to recruit Vps24-GFP to class E
compartments, although this truncation was sufficient to localize
to class E compartments (Figure S1B; W.M.H. and N.J.B.,
unpublished data). This suggests the need for an intact Snf7
core domain for Vps24 recruitment. Altogether, this indicates
that the molecular architecture of the ESCRT-III complex relies
primarily on core-core interactions between its subunits and
the endosome.
Snf7 Is Activated by Displacement of helix5 Away
from the Core
Because all ESCRT-III N-terminal core domains are sufficient to
localize to endosomal membrane and recruit other subunits of
the ESCRT-III complex, we reasoned that conformational
changes displacing the autoinhibitory C terminus promote
ESCRT-III assembly by exposing core contacts. We wanted to
understand these conformational changes and chose to focus
our investigation on Snf7, the most abundant ESCRT-III subunit.
Using crystal structures of hVps24 (CHMP3), we generated
a three-dimensional model of Snf7 in its ‘‘closed’’ conformation
by using the comparative protein structure modeling program
Modeler (Eswar et al., 2006) (Figure 2A). The Snf7 model adopts
the same overall fold as hVps24 and has four discernable
a helices composing its core domain, with a helix5 forming intra-
molecular contacts with the core.Cell 151, 356–371, October 12, 2012 ª2012 Elsevier Inc. 357
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Figure 1. N-Terminal Core Domains Mediate ESCRT-III Assembly
(A) Schematic of ESCRT-III subunit architectures. Helices are denoted as boxes. The MIT-interacting motif (MIM) is red.
(B–D) Representative images of vps20D, snf7D, or vps24D yeast expressing GFP-tagged full-length or core domains of ESCRT-III subunits (green). Class E
compartments are labeled with FM4-64 (red). Merged panels include GFP, FM4-64, and DIC images.
(E–G) Yeast lacking an ESCRT-III subunit and stably expressing a GFP-tagged downstream subunit are ectopically expressing either full-length (top), vector
(middle), or core domains (bottom). E, class E compartment.
Scale bar, 5 mm. See also Figure S1.We hypothesized that Snf7 activation involves the conforma-
tional displacement of helix5 away from its core contacts, allow-
ing the core domain to be accessible for potential protein and358 Cell 151, 356–371, October 12, 2012 ª2012 Elsevier Inc.membrane interactions. To investigate this conformational
change, we developed a cysteine-based crosslinking assay
that directly monitors the conformational state of Snf7. We first
selected residues on both helix5 (T179) and the core region
closely juxtaposed to helix5 (A51) (Figure S2A). Taking advan-
tage of the fact that endogenous Snf7 contains no cysteines,
we converted these residues to cysteines and purified Snf7T179C,
Snf7A51C, and the dicysteine mutant (Snf7redox) from E. coli
(Table S1).
In the presence of the reducing agent dithiothreitol (DTT), all
Snf7 cysteine mutants migrated to 37 kDa on SDS-PAGE
gels, which is consistent with cysteineless Snf7 (Figures 2B
and S2B). We next oxidized the cysteine-containing Snf7
mutants by adding the chemical oxidant copper(II) 1,10-phena-
throline (Cu2+Phen) and ran these samples on nonreducing
SDS-PAGE gels. Strikingly, Snf7redox underwent amigration shift
from37 kDa to30 kDa in the presence of Cu2+Phen, suggest-
ing intramolecular disulfide bond formation (Figure 2B). Snf7A51C
and Snf7T179C did not shift their migrations upon oxidization. The
Snf7redox migration shift indicates the disulfide crosslinking of
Snf7redox into an inactive ‘‘closed’’ conformation.
Because the Snf7redox migration shift may be correlated to its
‘‘open’’ and ‘‘closed’’ conformational states, we next asked
whether ESCRT subunits that initiate Snf7 activation promote
Snf7redox ‘‘opening.’’ Snf7 is activated by Vps20, which is itself
activated by the ESCRT-II subunit Vps25 (Saksena et al.,
2009). Thus, Vps25, Vps20, and liposomes were incubated
with Snf7redox in mildly reducing conditions to allow conforma-
tional changes within Snf7redox (Table S2). The samples were
then oxidized with Cu2+Phen and run on nonreducing SDS-
PAGE gels.
The separate incubation of Snf7 with either large unilamellar
vesicles (LUVs; 1 micron) or small unilamellar vesicles (SUVs;
<1 micron) failed to ‘‘open’’ Snf7redox (Figure 2C). Similarly,
experiments adding SUVs together with either Vps20 or Vps25
separately or adding Vps25 and Vps20 together but without
SUVs all failed to ‘‘open’’ Snf7redox (Figure S2C). However, the
complete addition of SUVs, Vps25, andVps20 caused adramatic
shift of Snf7redox from its ‘‘closed’’ to ‘‘open’’ conformational
state (Figure 2C). This effect was dose dependent, with
increasing concentrations of Vps20 and Vps25 inducing more
Snf7redox to an ‘‘open’’ conformation. This indicates that Vps25
and Vps20 promote the conformational ‘‘opening’’ of Snf7 on
membrane by displacement of helix5 away from the core
domain.
Structure-Based Mutations Promote Snf7 ‘‘Opening’’
Because Snf7 activation involves helix5 displacement, we
reasoned that mutations disrupting helix5-core contacts would
promote Snf7 activation and consequently drive Snf7 to endo-
somes. Using site-directed mutagenesis, we substituted resi-
dues R52 and L67 on the Snf7 core domain with glutamates,
which would disrupt helix5-core contacts, but not add additional
positive charge to Snf7 that may inadvertently promote
membrane binding (Figures S2A and S2D). To test whether these
substitutions promoted Snf7 activation, we first examined the
endosomal localization of the mutant proteins by subcellular
fractionation. Normally, 65% of Snf7 molecules localize to
the cytoplasmic supernatant fraction (S13) after a 13,0003
centrifugation spin (Babst et al., 2002). The remaining 35%
resides in the membrane-enriched pellet fraction (P13). Snf7R52Eand Snf7L67E displayed enhanced P13 fractionation (55% for
Snf7R52E and46% for Snf7L67E, respectively) (Figure 2D), which
is consistent with enhanced Snf7 activation.
We hypothesized that the R52E and L67E substitutions
would promote Snf7redox ‘‘opening.’’ To test this, we introduced
the R52E and L67E mutations into Snf7redox constructs and
oxidized the purified proteins with Cu2+Phen. As predicted,
the R52E and L67E substitutions enhanced the percentage of
Snf7redox remaining in an ‘‘open’’ state after their oxidation by
Cu2+Phen (R52E: 40% open; L67E: 38% open; versus
redox alone: 28% open) (Figure S2E). This suggests that
these mutations are disrupting the Snf7 closed conformation
by increasing the physical separation between the core and
helix5.
We next attempted to ‘‘open’’ Snf7 by mutating residues on or
near helix5 that make contact with the core domain. Although
helix5 primarily interacts with the core via weak hydrophobic
contacts, we noticed a highly conserved acidic patch in the linker
region immediately preceding helix5. This patch contains the
sequence motif EDEL(D/M)EE and is almost completely
conserved between yeast and man (Figure S2D). Several nega-
tively charged residues within this motif form electrostatic
contacts with positively charged residues along the core domain
(Figure S2A). Inversion of these negatively charged residues to
positively charged lysines (Snf7K-linker) significantly enhanced
Snf7 P13 fractionation (66% P13), suggesting that these muta-
tions may drive Snf7 ‘‘opening’’ by displacing the linker and
helix5 from contacting the core (Figure 2D). Snf7K-linker also
changed its migration pattern, likely due to a net change in
protein charge on SDS-PAGE gels.
Because our Snf7 mutants displayed enhanced P13 localiza-
tion, we wanted to directly assay their ability to interact with lipid
membranes. To do this, we next performed liposomes flotation
experiments with purified Snf7mutants to confirm that they inter-
acted with membranes better than ‘‘closed’’ wild-type Snf7.
Whereas wild-type Snf7 displayed very low liposome binding
(6%), Snf7R52E, Snf7L67E, and Snf7K-linker showed enhanced
liposome binding (27%, 38%, and 32%, respectively) (Figures
2E and S2F). As a positive control, the Snf7core domain alone
was purified and displayed the most robust membrane binding
(56%).
Taken together, these observations indicate that Snf7 exists in
an inactive ‘‘closed’’ conformation that involves intramolecular
contacts between the core domain and the linker-helix5 region.
We propose that when Vps20 is activated, it recruits Snf7 and
induces conformational changes within Snf7 that promote the
movement of the linker and helix5 away from the core. This
exposes regions of the core that were buried, allowing them to
interact with the endosome and other ESCRT-III subunits.
Several highly conserved lysines line the core domain and form
electrostatic contacts with the linker (Figure S2A). Once exposed
by conformational opening, they could potentially mediate Snf7
membrane binding (W.M.H. and N.J.B., unpublished data).
Activated Snf7 Assembles into Protofilaments
Once activated, Snf7 homo-oligomerizes, forming the most
abundant portion of the ESCRT-III complex (Teis et al.,
2008). Because Snf7R52E appeared to be autoactivated, weCell 151, 356–371, October 12, 2012 ª2012 Elsevier Inc. 359
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Figure 2. Snf7 Is Activated by Displacement of helix5 from Intramolecular Core Contacts
(A) Ribbon diagrams (side and top) of modeled Snf7 (residues 10–183).
(B) Coomassie-stained nonreducing SDS-PAGE gels of Snf7 cysteine mutants. Cu2+Phen denotes copper(II) phenathroline. The cartoons are ‘‘closed’’ Snf7 with
cysteines (orange).
(C) Snf7redox is conformationally ‘‘opened’’ by addition of Vps25, Vps20, and liposomes. LUV, large unilamallar liposomes; SUV, small unilamallar liposomes. Gels
are nonreducing.
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hypothesized that it would readily form higher-order structures
visible by negative stain transmission electron microscopy
(TEM). Whereas wild-type Snf7 does not assemble into ordered
structures (Figure 3A), we observed the robust assembly of
Snf7R52E into long protofilaments 14.5 ± 3.7 nm in diameter
(Figures 3B and 3C and Table S3).
Protofilament abundance and length were dependent on the
period of time samples incubated on TEM grids prior to negative
staining, suggesting that the Formvar grid was the site of proto-
filament formation (Figures S3A and S3C). Protofilament forma-
tion was also protein concentration dependent, with robust
formation at 34.5 mM, reduced protofilament formation at
12.5 mM, and no visible protofilaments under 5 mMconcentration
(Figure S3B). The protofilaments were often ‘‘capped’’ by rings
or spirals at one or both ends (Figures 3B–3F, red arrows).
Longer incubation times led to more abundant ring/spiral
‘‘caps’’ on protofilaments (see Figure S3D for quantification).
To further examine the molecular architecture of Snf7 protofi-
laments, we used 2% ammoniummolybdate as a negative stain.
Ammoniummolybdate forms a fine microcrystalline coat on bio-
logical samples, preserving their ultrastructural detail at the cost
of electron density. It had the general effect of sharpening the
resolution of Snf7 protofilaments and revealed that they are
composed of two intertwining subfilaments with a diameter of
4.1 ± 0.6 nm (Figures 3G–3K). Using ammonium molybdate,
the Snf7 protofilament diameter decreased to 9.0 ± 1.3 nm (Fig-
ure 3L). In rare samples, single subfilaments could be observed
but were generally short and broken (Figure 3I).
These observations indicate that the R52E mutation promotes
the assembly of Snf7 into homo-oligomeric protofilaments. The
basic unit of this oligomer is the 4 nm diameter subfilament.
Because the width of Snf7 monomers is 3–4 nm, we hypothe-
size that this subfilament is composed of ‘‘open’’ Snf7 mono-
mers arranged head to tail with one another (Figure 3K). Two
subfilaments then associate in parallel, forming a more stable
9 nm protofilament.
The Snf7 C-Terminal Region Stabilizes Protofilaments
Because the diameter of Snf7 subfilaments suggested that they
were composed of Snf7 monomers packed head to tail into
a chain, we hypothesized that Snf7core would be sufficient to
form protofilaments in vitro. Surprisingly, Snf7core failed to
assemble into protofilaments (Figures 4A and 4B). Consistent
with this, when Snf7core and Snf7R52E weremixed at 1:1 stoichio-
metric ratios, protofilaments were formed, but their lengths were
reduced dramatically (Figures S3E and S3F). This suggested that
Snf7R52E was able to interact with Snf7core, but Snf7core nega-
tively affected protofilament elongation.
Because Snf7core appeared to be unable to polymerize, we
hypothesized that the Snf7 C-terminal region may play a role in
Snf7 homo-oligomerization. To test this, we generated several
mutants that perturb the C-terminal region and evaluated these
mutations with three different assays to test: (1) whether the(D) Subcellular fractionations of snf7D yeast ectopically expressing Snf7mutants.
(E) Liposome flotation assays of reconstituted Snf7, Snf7R52E, and Snf7core. Lipos
the percentage Snf7 bound to liposomes as B/(B+U) (error bars denote mean ±S
See also Figure S2.mutants could assemble into protofilaments in vitro; (2) whether
they retained the ability to interact with endogenous Snf7 in vivo
by coimmunoprecipitation; and (3) whether the mutants were
able to complement ESCRT pathway function when expressed
in snf7D yeast.
We first investigated whether helix5 was involved in Snf7 olig-
omerization. We deleted helix5 (residues 170–183) on the R52E
background and found that purified Snf7R52E+Dhelix5 failed to
form protofilaments (Figure 4D). To test whether mutating helix5
affected Snf7 oligomerization in vivo, we next expressed
Snf7Dhelix5 in yeast with a chromosomally integrated SNF7-
3xFLAG gene and performed anti-FLAG immunoprecipitation.
Whereas wild-type Snf7 efficiently coimmunoprecipitated with
Snf7-FLAG (Figure 4C), Snf7Dhelix5 failed to coimmunoprecipi-
tate, indicating that the loss of helix5 attenuates Snf7 oligomeri-
zation (Figure 4D). This loss of function is not due to the nonspe-
cific deletion of residues within the C-terminal region because
deletion of residues immediately following helix5 (residues
185–195) did not affect ESCRT-III-dependent cargo sorting (Fig-
ure S4J). Importantly, Snf7R52E efficiently coimmunoprecipitated
with Snf7-FLAG, which is consistent with the ability of Snf7R52E
to assemble into protofilaments (Figure 4C).
If helix5 interacts in trans with neighboring Snf7 monomers,
then the highly conserved linker region would also be critical
for providing helix5 with the molecular ‘‘reach’’ necessary to
interact with another Snf7 monomer. Consistent with this, we
deleted the linker region (residues 151–170) and found that
Snf7Dlinker failed to form protofilaments (Figure 4E). Snf7Dlinker
also failed to coimmunoprecipitate with Snf7-FLAG in vivo,
suggesting that it is necessary for Snf7 oligomerization
(Figure 4E).
Because we found that charge-inversion mutations within the
linker region promote Snf7 activation, we examined Snf7K-linker
and found that it formed short (98 ± 73 nm length) protofilaments
(Figure 4F). In agreement, Snf7K-linker efficiently coimmunopreci-
pitated with Snf7-FLAG, again indicating that it was capable of
oligomerizing (Figure 4F). Together, these observations suggest
a role for the Snf7 C-terminal region in stabilizing Snf7 homo-
oligomers.
A pH-Sensitive ESCRTCargo Quantitatively Scores Snf7
Function
Previous studies have suggested that Snf7 homo-oligomeriza-
tion promotes ILV formation and thus the delivery of cargoes to
the vacuole lumen (Teis et al., 2008, 2010). Because we charac-
terized mutations that impaired Snf7 oligomerization, we next
developed an assay to quantitatively access their effects of
ESCRT pathway function. This assay utilizes a pH-sensitive
GFP variant (pHluorin) fused to the plasma membrane methio-
nine transporter Mup1 (Prosser et al., 2010) (see Figure 4K for
conceptual model) (Table S4).
When extracellular methionine levels are low, Mup1-pHluorin
localizes to the plasma membrane and fluoresces brightlyHistograms represent averages of three independent experiments. SDs shown.
ome-bound (B) and unbound (U) fractions are denoted. Histograms represent
D).
Cell 151, 356–371, October 12, 2012 ª2012 Elsevier Inc. 361
A B
C
D
E
F
G H I
J
K L
Figure 3. Snf7 Assembles into Protofilaments
(A) TEM micrograph showing that Snf7 (wild-type) does not oligomerize.
(B–F) Snf7R52E assembles into long protofilaments that terminate in rings (red arrows).
(G) Snf7R52E protofilaments are composed of intertwining subfilaments.
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when excited (Figure 4G). In response to increased extracellular
methionine, Mup1 is rapidly endocytosed and delivered to the
vacuole lumen in an ESCRT-dependent manner (Figure S4A)
(Lin et al., 2008). At the vacuole, pHluorin fluorescence is
quenched due to the acidity of the vacuole lumen (Figure 4H).
Because ESCRT dysfunction results in a failure to sort Mup1-
pHluorin into ILVs, we predicted that cells with a defective
ESCRT-III would display persistent pHluorin fluorescence in
the presence of methionine (Figures 4I and 4J). In this way,
pHluorin fluorescence intensity is a quantifiable readout of the
efficiency of ESCRT-III-mediated ILV formation.
To quantitatively score mutations that affect Snf7 oligomeriza-
tion, we ectopically expressed Snf7 mutants in Mup1-pHluorin-
expressing yeast lacking endogenous Snf7 and induced
Mup1-pHluorin endocytic uptake by adding methionine. We
then used flow cytometry to quantify the pHluorin fluorescence
intensities of at least 300,000 yeast expressing each mutant.
When the fluorescence distribution of the population was
plotted, each Snf7 mutant exhibited a unique and highly repro-
ducible sorting profile (Figure S4C). We then calculated the
percent deviation of each mutant from the wild-type profile to
assign a ‘‘score’’ that reflects the severity of each mutation on
ESCRT pathway function. The table in Figure 4L summarizes
these calculations.
Notably, 79% of yeast expressing Snf7R52E sort Mup1-
pHluorin as efficiently as wild-type cells, resulting in a sharply
peaked sorting profile that is only slightly brighter when
compared to wild-type yeast (Figure S4C). This indicates that
Snf7R52E retains functionality in vivo. Although the precise reason
for the slight fluorescence shift is unclear, it may be attributed to
perturbing the assembly:disassembly equilibrium of ESCRT-III,
which may affect ILV formation. Consistent with this, mutations
localized within the helix5-core contact site elicited Mup1-
pHluorin sorting defects (L67E and A51E), whereas mutations
outside this region had almost no effect on sorting (K60E and
K79E) (Figures S4B and S4C).
Consistent with the need for helix5 to efficiently oligomerize
in vitro, Snf7Dhelix5-expressing yeast displayed a significant
Mup1-pHluorin sorting defect, resulting in only32%of the sort-
ing efficiency of wild-type cells (Figure 4L). Snf7Dlinker-expressing
yeast also failed to efficiently sort Mup1-pHluorin, functioning at
only 9% of wild-type levels. This was similar to Snf7core alone,
which had a sorting phenotype similar to snf7D yeast. Surpris-
ingly, Snf7K-linker also failed to sort Mup1-pHluorin efficiently
(7% sorting efficiency). The reason for this is unclear but may
be due to the inherent instability of the short (100 nm) filaments
this mutant formed (Figure 4F).
To confirm that the sorting of Mup1 represents a general
readout of ESCRT pathway function, we examined the sorting
of another ESCRT-dependent cargo—the vacuolar protease
Cps1. Snf7 mutants were coexpressed in yeast expressing
GFP-Cps1, which is sorted from the Golgi to the vacuole in an(H and I) Zoom-ins of the Snf7R52E protofilament in (G) showing subfilament inter
(J) Snf7R52E protofilament terminating in a ring. The red arrow denotes subfilame
(K) Model of subfilament packing in the Snf7 protofilament.
(L) Quantitation of Snf7 filament diameters. Scale bars, 100 nm (A–G) and 50 nm
See also Figure S3.ESCRT-dependent manner. The qualitatively scored ability of
mutants to sort GFP-Cps1 closely matched the sorting profiles
of Mup1-pHluorin (Figures S4D–S4K), suggesting that the
Mup1-pHluorin sorting profile represents the general sorting
capability of the ESCRT pathway.
Altogether, these data underscore the involvement of the Snf7
C-terminal region in stabilizing Snf7 homo-oligomers. It suggests
that this region, following subunit ‘‘opening,’’ may form contacts
with a neighboring Snf7 monomer to promote oligomerization.
Furthermore, the use of Mup1-pHluorin as a pH-sensitive cargo
has allowed us to quantitatively access the effect of individual
point mutations within the ESCRT pathway.
Snf7 Assembles into Spirals on Lipid Monolayers
Because we reconstituted Snf7 oligomerization and showed its
importance in the sorting of cargoes to the vacuole, we next
wanted to visualize Snf7 assembly directly on a lipid environ-
ment. To directly visualize ESCRT-III assembly on lipids and
to retain the high visual resolution of transmission electron
microscopy, we generated supported lipid monolayers along
the surface of Formvar-coated TEM grids (Figures 5A and
5B). Monolayers of defined lipid composition (see Extended
Experimental Procedures) formed spontaneously across the
surface of an aqueous buffer and were subsequently adhered
to TEM grids. Proteins could then be injected, allowing the
assembly of protein structures on the supported monolayer
surface.
We first added purified Snf7R52E to lipid monolayers and
observed the robust assembly of Snf7R52E into protofilament
spirals across the monolayer surface (Figure 5C). Spirals were
an average outer diameter of 50.4 ± 9.8 nm (Figure S5A). By
examining regions of grids that were not coated with monolayer,
we noted that Snf7 spirals closely resemble the more elongated
Snf7 protofilaments formed on grids but were more tightly coiled
into spirals when assembled on a lipid environment (Figure 5C,
top region).
We hypothesized that the negatively charged phosphatidyl-
serine (PS) and PtdIns(3)P lipids within the monolayer (30%
PS, 10% PtdIns(3)P) mediated electrostatic interactions with
Snf7 and promoted spiral assembly. To test this, we generated
lipid monolayers with a reduced electrostatically positive lipid
composition (now 5% PS, 1% PtdIns(3)P). As predicted, Snf7
failed to associate into tightly coiled spirals on this monolayer
surface (Figure S5B).
Snf7, Vps24, and Vps2 Coassemble into Protein Helices
Spirals are geometrically two-dimensional structures. In agree-
ment with this, the Snf7 spirals we observed appeared ‘‘flat’’
and thus ostensibly incapable of mediating the drastic three-
dimensional membrane remodeling necessary for ILV formation.
Because Snf7 oligomerization recruits ESCRT-III subunits Vps24
and Vps2 to endosomes, we hypothesized that these proteinstwining.
nt hypercoiling in the ring.
(H–J).
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Figure 4. The Snf7 C-Terminal Region Stabilizes Snf7 Homo-Oligomers
(A and B) TEM micrographs of Snf7R52E and Snf7core.
(C) Anti-FLAG coimmunoprecipitations to detect Snf7-Snf7 interaction. The schematic denotes the experimental design.
(D–F) TEM micrographs of Snf7 mutants with their corresponding coimmunoprecipitations and assembly model to their right.
(G–J) Representative images of yeast expressing Mup1-pHluorin (green) and Snf7 constructs (indicated) in the absence of methionine (G) and after methionine
induction (H–J). FM4-64 is red. To the right of each image is the sorting profile of 100,000 yeast plotted by FITC channel intensity and cell number.
(K) Conceptual model for the pHluorin sorting assay.
(L) Table summarizing the effect of ESCRT mutations on Mup1 vacuole delivery. SD is reported. Scale bars, 100 nm (A–F) and 5 mm (G–J).
See Figure S4.
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Figure 5. Snf7 Assembles into Spirals on Lipid Monolayers and Coassembles with Vps24 and Vps2 into Helices
(A) Schematic showing lipid monolayer creation.
(B) TEM micrograph of lipid monolayer. The monolayer ‘‘edge’’ is marked by an arrow.
(C) Snf7R52E protofilaments assembled directly on lipidmonolayers. More linear protofilaments assembled on the ‘‘naked’’ grid (top region). The panels to the right
are zoom-ins of several Snf7 spirals.
(D) Snf7R52E forming linear filaments on a grid.
(E and F) Snf7R52E, Vps24, and Vps2 coassembling into helices (arrows) on a grid.
(G–I) Snf7R52E:Vps24:Vps2 helices assembled on lipid monolayers.
(J) Speculative model of a Snf7 spiral and Snf7:Vps24:Vps2 helix that may drive membrane invaginations.
Scale bars, 100 nm. See also Figures S5 and S6.may modulate the molecular architecture of Snf7 polymers
(Babst et al., 2002; Teis et al., 2008). To test this, we reconsti-
tuted full-length Vps24 and Vps2 from E. coli and incubated
them with Snf7R52E at cellular abundance levels (2:1:1 ratios;
Snf7:Vps24:Vps2) (Figure S5C).We first examined these coassembly experiments on TEM
grids. As before, Snf7R52E alone polymerized into long protofila-
ments capped with a ring or spiral (Figure 5D). Strikingly, the
simultaneous addition of Snf7R52E, Vps24, and Vps2 generated
coiled helices (a geometrically three-dimensional spiral) thatCell 151, 356–371, October 12, 2012 ª2012 Elsevier Inc. 365
extended across the grid surface (Figures 5E and 5F). The fila-
ments composing these helices were identical in diameter to
Snf7R52E protofilaments (9 nm) but were generally shorter
and of variable length (mean length: 290 ± 185 nm) (Figure S5G).
These helical polymers are likely hetero-oligomers containing
Snf7R52E, Vps24, and Vps2 because experiments including
only two of the three subunits at 1:1 ratios did not produce
helices (Figures S5D and S5E). Similarly, coincubated Vps24
and Vps2 (1:1) failed to oligomerize, likely because there was
no Snf7 present to induce Vps24/Vps2 activation (Figure S5F).
We next added Snf7R52E, Vps24, and Vps2 to lipid mono-
layers. The proteins again assembled into helices similar to those
formed on TEM grids. High magnification of these helices indi-
cated that they appeared to retain a three-dimensional coiling
architecture indicative of protein helices like those formed by
the membrane scission machine dynamin (Carr and Hinshaw,
1997) (Figures 5G–5I). These helices projected across the mono-
layer surface andwere very distinct from the spirals that Snf7R52E
formed on its own. They displayed an average outer diameter of
85.4 ± 6.5 nm. Several were closely associated with liposomes
that spontaneously form as a byproduct of monolayer biogen-
esis, suggesting that the helices can readily interact with lipid
membranes (Figures 5G–5I).
Because Vps24 and Vps2 are recruited to endosomes after
Snf7, we next asked whether these proteins could remodel
pre-existing Snf7 protofilaments into helices. To do this, we
assembled Snf7 into protofilaments on TEMgrids, washed unas-
sembled protein away by droplet exchange, and added buffer
containing Vps24 and Vps2 to the grids. We then examined
the grids and qualitatively scored for the efficiency of helix
formation relative to a control grid containing coincubated
Snf7:Vps24:Vps2. When Vps24 and Vps2 were added to preas-
sembled Snf7 protofilaments, they were able to efficiently induce
helix formation (Figure S5H, i and ii). Similarly, we also observed
slightly less efficient helix formation when Snf7R52E and Vps24
were first added to grids, followed by a wash and Vps2 (Fig-
ure S5H, iii). In contrast, sequential addition of Snf7R52E,
Vps24, and Vps2 in three stages, or the addition of Vps24 and
Vps2 first, followed by Snf7R52E led to drastically reduced helix
formation (Figure S5H, iv and v). These experiments imply that
Vps24 and Vps2 could potentially remodel pre-existing Snf7
polymers into helices during the ordered assembly of ESCRT-
III (Figure 5J).
Vps24 and Vps2 Promote ESCRT-III-Associated
Membrane Invaginations on GUVs
Although TEM imaging of lipid monolayers provides high-resolu-
tion visualization of ESCRT-III assembly, the monolayers are
adhered to a rigid grid support and thus cannot be deformed
by ESCRT-III (Figure S5I). Because Snf7, Vps24, and Vps2 coas-
sembled into helices with impliedmembrane-sculpting potential,
we next wanted to investigate whether these proteins could drive
or be associated with membrane invaginations. Because we
could not visualize membrane invaginations on SUVs or LUVs
by light microscopy, we generated giant unilamellar vesicles
(GUVs) labeled with the lipophilic dye DiI. We noted that some
GUVs could spontaneously deform in solution, so we wanted
to ensure that we could distinguish membrane invaginations366 Cell 151, 356–371, October 12, 2012 ª2012 Elsevier Inc.that were specifically associatedwith ESCRT-III proteins.We flu-
orescently tagged Snf7R52E by substituting a cysteine into its
C terminus (V187C) to which we covalently attached a malei-
mide-conjugatable Alexa488 fluorophore (Figure S6A). Although
Snf7R52E-A488 was able to interact with GUVs (Figure S6B), we
wanted to reconstitute full ESCRT-III assembly and so purified
Vps20core, which was sufficient to recruit Snf7 to endosomal
membranes (Figure 1E). GUVs treated with Vps20core and
Snf7R52E-A488 displayed punctal Snf7R52E-A488 labeling across
their surfaces but were notably devoid of ESCRT-III-associated
invaginations (Figures S6C and S6I).
In striking contrast, the addition of all four ESCRT-III subunits
(now including Vps24 and Vps2) led to the formation of distinct
membrane invaginations with which Snf7R52E-A488 punctae
associated (Figures S6D–S6G). Snf7R52E punctae stably associ-
ated with these invaginations over time, and several invagina-
tions were observed to form underneath sites of Snf7R52E
enrichment, suggesting that they may form as a consequence
of ESCRT-III assembly (Figure S6H and Movie S1). Interestingly,
Snf7R52E-A488 remained at the top, neck region of these invag-
inations and was mostly excluded from the bud that protruded
into the GUV interior. This may indicate that ESCRT-III assem-
blies containing Snf7R52E may have affinity for regions of high
membrane curvature located at the necks of membrane
invaginations.
Together with our TEM-based observations, we propose
that Vps24 and Vps2 induce structural rearrangements in Snf7
polymers that create helices with potential membrane-sculpting
properties (Figure 5J). We speculate that, because of the
rigidity of TEM grid support, these helices cannot deform the
lipid monolayer on which they assemble. Instead, they stably
associate with the monolayer surface and extend across it
(Figure S5I).
ESCRT-II Regulates the Assembly of Snf7 Rings
Wewere intrigued by the architectural changes in Snf7 oligomers
when we added downstream ESCRT-III subunits Vps24 and
Vps2 to our reactions. Next, we wanted to investigate how
upstream ESCRT machinery may affect Snf7 protofilament
architecture. Prior to vesicle formation, ESCRT-II initiates the
assembly of ESCRT-III at sites enriched with ubiquitinated
cargo. We wanted to investigate the structural relationship
between ESCRT-II and ESCRT-III, so we next attempted
to reconstitute the coassembly of complete ESCRT-II and
ESCRT-III complexes.
ESCRT-II was purified as a complex by virtue of a hexahistidine
(His6) tag on Vps36 (Figure 6A). ESCRT-II and Vps20 were then
coincubated with Snf7R52E at an 1:2:10 ratio (ESCRT-II:
Vps20:Snf7R52E) and examined by TEM. This reaction yielded
TEMgrids covered with small rings instead of the linear protofila-
ments normally observed when Snf7R52E was imaged alone
(Figures 6B and 6C). Rings measured 65.1 ± 22.1 nm in diameter
(Figures 6G and 6H), and many exhibited distinct globular densi-
ties at one point along their circumference. The rings were
composed of highly curved 9 nm diameter protofilaments,
suggesting that they were composed of two Snf7 subfilaments.
Ring formation required the presence of ESCRT-II, Vps20, and
Snf7R52E, as removal of either ESCRT-II or Vps20 drastically
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Figure 6. ESCRT-II Mediates ESCRT-III Ring Formation
(A) Coomassie-stained gel of reconstituted ESCRT-II.
(B) Snf7R52E protofilaments.
(C) ESCRT-II, Vps20, and Snf7R52E (1:2:10 ratio) coassemble into rings.
(D) Labeling of His6-ESCRT-II using 5 nm Ni2+NTA nanogold beads.
(E) ESCRT-II:ESCRT-III ring supercomplexes with nanogold-labeled ESCRT-II.
(F) Model of ESCRT-II:Vps20:Snf7 ring complex.
(G) Histogram of ESCRT-II:Vps20:Snf7R52E ring diameters.
(H) Scatterplot of ring diameters measured in perpendicular x and y planes.
Scale bars, 100 nm. See also Figure S7.reduced ring formation in favor of linear protofilaments (Figures
S7A–S7C).
We hypothesized that the globular densities associated with
these rings represented ESCRT-II complexes that were poten-
tially modulating ESCRT-III ring formation. When ESCRT-II was
examined by TEM, globular protein densities 14.6 ± 2.9 nm in
diameter were observed that appeared very similar to the densi-ties associated with ESCRT-III rings (Figure 6D). Crystallo-
graphic studies suggest that this diameter is consistent with
the predicted size of negatively stained ESCRT-II complexes
(Hierro et al., 2004). To confirm that these densities were
indeed ESCRT-II, the complex was preincubated with 5 nm
Ni2+NTA-coated nanogold beads, which can bind His6-tags
with high affinity. Single 5 nm nanogold beads now decoratedCell 151, 356–371, October 12, 2012 ª2012 Elsevier Inc. 367
the protein densities, confirming that they were ESCRT-II
(Figure 6D).
We next added Vps20 and Snf7R52E with an ESCRT-II sample
that was preincubated with 5 nm nanogold beads. We observed
protein rings dotted by a single nanogold-labeled ESCRT-II (Fig-
ure 6E). These observations suggest that ESCRT-II and Vps20
may coordinate the polymerization of Snf7 polymers into highly
curved ESCRT-II:ESCRT-III supercomplexes (Figure 6F).
Interestingly, when ESCRT-II, Vps20, Snf7R52E, Vps24, and
Vps2 were all coincubated at a 1:2:10:5:5 ratio, almost no helical
protofilaments were observed. Instead, we observed primarily
rings with diameters 70.2 ± 18.6 nm, which are similar to
those formed by only ESCRT-II, Vps20, and Snf7R52E (Figures
S7D–S7F).
Altogether, these data suggest that ESCRT-II and Vps20 may
coordinate the architecture of Snf7 polymerization, favoring the
formation of highly curved rings. These rings provide a possible
structural explanation for the physical sequestration of trans-
membrane cargoes at distinct regions of the endosome surface
prior to their packaging into vesicles.
DISCUSSION
The ESCRT pathway mediates the capture, sequestration, and
sorting of transmembrane proteins into multivesicular bodies
that are ultimately delivered to the vacuole for degradation.
The sequential assembly of distinct ESCRT complexes suggests
an exquisite division of labor to achieve cargo sorting. Whereas
ESCRTs-0, -I, and -II form stable hetero-oligomeric complexes,
the dynamic cycling of ESCRT-III subunits from inactive mono-
mers into active polymers drives the formation of cargo-laden
vesicles. Here, we have reconstituted distinct stages of this
dynamic ESCRT-III assembly that provide structural insights
for how ESCRT-III achieves both cargo capture and vesicle
formation.
Based on this work and the collective work of the ESCRT field,
we propose a comprehensive model for ESCRT-mediated MVB
biogenesis: (1) ESCRT-0, -I, and -II engage ubiquitinated cargo
and concentrate this cargo into a patch on the endosome
surface; (2) ESCRT-II initiates the assembly of an ESCRT-III
ring-like polymer by directly binding Vps20; (3) ESCRT-III assem-
bles by the sequential recruitment of its subunits, ultimately
forming a helix; and (4) the AAA ATPase Vps4 is recruited by
ESCRT-III to recycle the ESCRT machinery off the MVB.
In our present work, we engineered precise residue substitu-
tions that drive the robust oligomerization of Snf7. We then
used a combination of TEM, biochemical, and cell biological
techniques to elucidate the mechanism for Snf7 oligomeric
assembly. Reconstituting Snf7 activation allowed us to charac-
terize distinct subreactions that occur during the ordered
assembly of ESCRT-III. Ultimately, we propose that ESCRT-II
and ESCRT-III coassemble into cargo-capturing ring complexes
that are transformed into membrane-sculpting helices to drive
ILV formation.
When assembled on an endosome, an 65 nm diameter
protein ring would enclose 3,320 nm2 of membrane surface.
If this membrane area were remodeled into a sphere, it would
form a vesicle 32 nm in diameter, which is consistent with the368 Cell 151, 356–371, October 12, 2012 ª2012 Elsevier Inc.observed size of ILVs in yeast MVBs (Wemmer et al., 2011).
Thus, we propose that an ESCRT-II:ESCRT-III ring supercom-
plex assembles on the endosome surface and simultaneously
mediates (1) physical sequestration of transmembrane cargoes
that will be packaged into the ILV and (2) demarcation of the
membrane surface area that is sculpted into the cargo-laden
ILV (Figures 7A and 7B). Following Snf7 homo-oligomerization,
Vps24 and Vps2 are recruited to the assembling ESCRT-III
complex, potentially promoting the formation of an ESCRT-III
helix with vesicle-sculpting properties (Figures 7C and 7D).
Recent studies using GUVs demonstrated that ESCRT-III
constitutes the minimal machinery necessary to achieve ILV
formation in vitro (Wollert and Hurley, 2010). Although these
studies indeed highlighted the abilities of ESCRT-III to bind to
and deform membranes, they were limited by the resolution of
fluorescence microscopy and therefore provided little informa-
tion as to the architecture that ESCRT-III adopts during vesicle
budding. Here, we have investigated the underlying molecular
mechanism of ESCRT-III-mediated membrane sculpting by
using the high visual resolution provided by TEM. Surprisingly,
we find that specific ESCRT subunits modulate distinct architec-
tural stages of ESCRT-III assembly. This is consistent with the
fact that all core ESCRT proteins are essential to MVB cargo
sorting; the loss of any subunit blocks cargo delivery to the
vacuole.
ESCRT-II and Vps20 Mediate Snf7 Ring Formation
for Cargo Capture
ESCRT-II and Vps20, which physically links ESCRT-II to Snf7,
appear to regulate both the size and shape of Snf7 oligomers.
As such, ESCRT-II and Vps20 promote the formation of rings
65 nm in diameter that are ideal for physically capturing and
sequestering ubiquitinated cargoes at the endosome. Because
ESCRT-II contains two Vps25 subunits that each interact with
a Vps20, a two-armed ESCRT-II may coordinate the formation
of ESCRT-III rings by interacting with both Snf7 subfilaments
simultaneously. This is consistent with previous studies indi-
cating that a two-armed ESCRT-II was necessary for ILV forma-
tion in yeast (Teis et al., 2010).
Although ESCRT-II promotes the formation of highly curved
ESCRT-III rings, it is notable that Snf7 protofilaments naturally
spiral on lipid membranes. This intrinsic curvature is likely deter-
mined on the molecular level by specific interactions between
Snf7 monomers that set the curvature pitch of the polymer.
The flexibility of the Snf7 linker region, which has been shown
in other ESCRT-III subunits to be associated with conformational
changes, may also provide flexibility that allows protofilament
bending (Lata et al., 2008).
Other protein polymers have been shown to undergo drastic
changes in shape due to conformational changes within their
monomers. FtsZ, a bacterial cytoskeletal protein, assembles
into straight homo-oligomeric protofilaments that are converted
into spirals and rings by conformational changes within their
monomers (Lu et al., 2000). Furthermore, these architectural
dynamics can generate mechanical force that bends lipid
membranes (Osawa et al., 2009). FtsZ and ESCRT-III have
both been proposed to play direct roles in themembrane remod-
eling necessary for cytokinesis, implying that there may be
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Figure 7. Proposed Model for ESCRT-III-Mediated MVB Biogenesis
(A–C) Speculative cartoons illustrating three stages in ESCRT-mediated vesicle budding from a ‘‘top’’ perspective over the endosome surface.
(D) A ‘‘side’’ view of the proposed mechanism of ESCRT-mediated vesicle budding.conceptual similarities shared between the dynamics of the pro-
tofilaments they form.
Vps24 and Vps2 Promote ESCRT-III Helix Formation
Whereas ESCRT-II and Vps20 initiate ESCRT-III assembly that
may promote capture cargo, we propose that Vps24 and Vps2
are recruited after cargo sequestration to transform ESCRT-III
into a membrane-deforming helix. They achieve this by directlymodulating the three-dimensional architecture of Snf7 filaments.
By itself, Snf7 assembles into spirals that are ostensibly inca-
pable of membrane deformation. The helices generated by the
coassembly of Snf7, Vps24, and Vps2 are architecturally distinct
from these spirals and closely resemble protein helices formed
by the membrane-sculpting protein dynamin (Carr and Hinshaw,
1997). One intriguing hypothesis is that the Snf7-dependent
recruitment of Vps24 and Vps2 to endosomes causes Snf7Cell 151, 356–371, October 12, 2012 ª2012 Elsevier Inc. 369
spirals to reorganize into helices, thus driving membrane invag-
inations by a ‘‘molecular spring’’-like mechanism. Protofilament
remodeling may generate mechanical force that ultimately leads
to membrane bending and the formation of a vesicle that buds
into the endosomal interior (Figures 7C and 7D). The fact that
Vps24 and Vps2 can remodel pre-existing Snf7 protofilaments
into helices supports this model (Figure S5H). This is further
supported by GUV-based experiments showing that Vps24
and Vps2 promote the association of fluorescent Snf7 with
membrane invaginations (Figures S6D–S6H). This model also
agrees with the proposed ordered assembly of ESCRT-III (Teis
et al., 2008).
Recent studies observed 17 nm diameter ESCRT-III-depen-
dent helical filaments along the plasma membrane of cells
undergoing cytokinetic abscission (Guizetti et al., 2011). Human
Snf7 and Vps2 localized along these filaments and were neces-
sary for their assembly. One intriguing hypothesis is that the
ESCRT-III helices presented here represent structural analogs
of the filaments that purportedly drive mammalian cytokinetic
abscission, suggesting structural conservation in ESCRT func-
tion between different biological processes.
Although we observed that Vps24 and Vps2 promoted the
formation of protein helices, we did not detect Vps24/Vps2
‘‘domes’’ in our assembly reactions, which have been previously
implicated as mediators of ILV formation (Lata et al., 2008). In
these studies, ‘‘domes’’ formed in the absence of Snf7 and
only through significant truncation of Vps24 and Vps2. The
experiments presented here indicate that Snf7, Vps24, and
Vps2 may coassemble into a hetero-oligomeric helix to achieve
ILV budding.
The Architecture of ESCRT-III Is Similar to Other
Membrane-Sculpting Oligomers
The ESCRT-III structures observed in this study are conceptually
reminiscent of the membrane scission machines FtsZ and
dynamin. Both of these proteins oligomerize during membrane
remodeling, as well as interact with other proteins that modulate
their architectural dynamics. Intriguingly, FtsZ interacts with
FzlA, a protein recently shown to transform linear FtsZ protofila-
ments into spiraling helices in vitro (Goley et al., 2010). Similarly,
dynamin forms helices that work cooperatively with BAR and
F-BAR proteins to mediate clathrin vesicle release.
One obvious difference between FtsZ, dynamin, and
ESCRT-III is that FtsZ and dynamin directly hydrolyze guanosine
triphosphate (GTP). This induces architectural changes that
promote membrane scission. Although ESCRT-III subunits do
not hydrolyze NTPs directly, they recruit the AAA ATPase Vps4
that provides energy via ATP hydrolysis. This energy may either
be ‘‘stored’’ by ESCRT-III subunits in their ‘‘closed’’ conforma-
tions or added directly to ESCRT-III through physical contact
with ESCRT-III helices. Thus, the 85 nm diameter ESCRT-III
helices presented here may represent a ‘‘relaxed’’ state that
could be constricted or even broken by Vps4.
A Working Model: ESCRT-III Adopts Multiple
Architectures to Achieve Cargo Sorting
The existence of distinct architectural forms to ESCRT-III
suggests that it matures through at least two stages during its370 Cell 151, 356–371, October 12, 2012 ª2012 Elsevier Inc.ordered assembly: (1) early-stage assembly that creates a
cargo-sequestering ring of defined size and (2) late-stage
assembly that generates a membrane-sculpting helix for ILV
formation.
Several in vivo observations support the existence of distinct
stages to ESCRT-III assembly. Vps24 and Vps2 constitute
a subcomplex and are recruited during or after Snf7 polymeriza-
tion, which is consistent with their role as ‘‘late’’ modulators of
ESCRT-III architecture. Furthermore, deletion of either Vps24
or Vps2 blocks ILV formation, but not cargo sequestration at
endosomes (Teis et al., 2010). Consistent with this are studies
showing that blockage of late stages of the ESCRT pathway
lead to receptor enrichment at late endosomes and sustained
EGF signaling (Babst et al., 2000). These phenomena could be
explained by the formation of ESCRT-II:ESCRT-III rings that
sequester cargo but fail to execute vesicle formation.
Despite direct visualization of ESCRT-III oligomers, several
key questions remain. The most pressing is the mechanism
by which ESCRT-III mediates vesicle scission. The structures
observed in this study indicate several possible mechanisms.
Vps4 could engage the ESCRT-III helix and drive filament sliding
or constriction. This would narrow the ILV neck to a point of
spontaneous collapse at the helix base, liberating the vesicle
without consuming ESCRT-III itself (Figure 7D). Furthermore,
the disassembly of ESCRT-III by Vps4 may destabilize the
highly curved neck region, leading to membrane buckling
and scission. In direct contrast to some previous studies,
we noted that ESCRT-III often associates with membrane
invaginations on GUVs for long periods of time (often several
minutes). The presence of ESCRT-III proteins did not lead to
‘‘efficient’’ scission independent of Vps4 in these cases (Fig-
ure S6; W.M.H., unpublished data). As such, conclusions
concerning Vps4-independent vesicle scission by ESCRT-III
may need careful re-evaluation. No doubt future studies are
needed to further reveal insights about the remarkable ESCRT-
III pathway.EXPERIMENTAL PROCEDURES
Negative Stain Transmission Electron Microscopy
Samples were incubated for 30 min at room temperature and then added to
carbon-coated Formvar grids (EMS). Droplets were incubated for 10 min
and then negative stained. All samples were examined on an FEI Morgnani
Transmission Electron Microscope at 80–100kV. Digital images were taken
using an AMT camera. Micrographs are representative of results frommultiple
experimental sessions. Distance quantitation was conducted by using ImageJ
(NIH). For additional information, see Supplemental Information.Liposome Flotation Assays
1 mg/ml of 60% phosphatidylcholine (PC):30% phosphatidylserine (PS):10%
phosphatidylinositol 3-phosphate (PtdIns(3)P) (Avanti) liposomes were gener-
ated by classical dehydration in a chloroform:methanol mix and then resus-
pended in 500 ml Buffer A. Liposomes were sonicated for 1min and thenmixed
with 14 mM protein and incubated for 30 min. Samples were resuspended in
30% sucrose buffer layered with a 20% and 0% cushion and centrifuged in
a TLS-55 ultracentrifuge rotor (Beckman Coulter) for 1 hr at 55,000 rpm. The
top ‘‘float’’ fraction was separated from the bottom ‘‘unbound’’ fraction, TCA
precipitated, run on SDS-PAGE gels, and Coomassie stained.
For a detailed summary of the Snf7redox assay, see Supplemental
Information.
Mup1-pHluorin ESCRT Cargo-Sorting Assay and Flow Cytometry
A yeast strain (NBY44) stably expressing Mup1-pHluorin and ectopically
expressing various Snf7 constructs was incubated to early log growth.
Mup1-pHuorin endocytic uptake was induced by addition of methionine as
previously described (Lin et al., 2008). Yeast were reconstituted into PBS
and analyzed by using a BD Bioscience LSRII cytometer. Approximately
100,000 yeast per experiment were evaluated in at least three independent
experiments for each mutant. Sorting profiles were obtained by overlaying
the composite wild-type trace on composite mutant traces. For additional
information, see Supplemental Information.
For a detailed summary of additional experimental procedures, see
Extended Experimental Procedures.
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